
"The shift from drugs to devices is less a revolution than an infrastructure buildout"
Carter Sciences' #Neurotech Newsletter explores the companies rethinking #MentalHealth from the ground up
@flowneurosci @BrainsWay @magnus_medical @INBRAINNeuro bit.ly/4cPu8dC
English